Singlomics - Web3 Crypto Company Profile, Funding, Valuation, Investors - Cointime

Bitcoin $79,784.13 +5.06%
Ethereum $3,212.23 +6.81%
BNB $639.72 +3.88%
Optimism $1.71 +8.29%
Arbitrum $0.64 +9.60%
Solana $211.19 +7.60%
Polygon $0.41 +9.99%
Cosmos $5.44 +16.41%
Avalanche $32.72 +13.92%

Bitcoin $79,784.13 +5.06%
Ethereum $3,212.23 +6.81%
BNB $639.72 +3.88%
Optimism $1.71 +8.29%
Arbitrum $0.64 +9.60%
Solana $211.19 +7.60%
Polygon $0.41 +9.99%
Cosmos $5.44 +16.41%
Avalanche $32.72 +13.92%

Singlomics

company

Summary
Funding Rounds
Investors

About

Singlomics uses single-cell sequencing technology for antibody drug discovery.

Highlights

Total Funding Amount

Details

Last Funding Type: Series B
Last Funding Money Raised: ¥300M
Industries: Biotechnology,Health Care,Medical
Founded date: Jan 1, 2020
Operating Status: Active

Singlomics uses single-cell sequencing technology to develop antibody drugs for the treatment of infectious diseases and cancers.

Funding Rounds

Number of Funding Rounds

Total Funding Amount

1

¥300M

Singlomics has raised a total of ¥300M in funding over 2 rounds. Their latest funding was raised on Feb 2, 2022 from a Series B round.

Announced Date	Round	Money Raised	Number of Investors	Lead Investors	Post Valuation
Feb 2, 2022	Series B	¥300M	3	—	—	Detail

Investors

Number of Lead Investors

Number of Investors

—

3

Singlomics is funded by 3 investors. JIANYI CAPITAL and Witruth Capital are the most recent investors.

Investor Name	Lead Investor	Funding Round
JIANYI CAPITAL	—	Series B
Witruth Capital	—	Series B
Ruihua Venture Capital	—	Series B